Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026)
Beta Bionics' Cash from Financing Activities history spans 3 years, with the latest figure at $623000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 99.7% to $623000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.4 million, a 98.36% decrease, with the full-year FY2025 number at $214.9 million, up 286.36% from a year prior.
- Cash from Financing Activities hit $623000.0 in Q1 2026 for Beta Bionics, down from $1.1 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for BBNX hit a ceiling of $211.1 million in Q1 2025 and a floor of -$1.2 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $30.1 million across 3 years, with a median of $623000.0 in 2026.
- Biggest five-year swings in Cash from Financing Activities: surged 3518550.0% in 2025 and later tumbled 99.7% in 2026.
- Tracing BBNX's Cash from Financing Activities over 3 years: stood at $56.9 million in 2024, then plummeted by 98.14% to $1.1 million in 2025, then crashed by 41.23% to $623000.0 in 2026.
- Business Quant data shows Cash from Financing Activities for BBNX at $623000.0 in Q1 2026, $1.1 million in Q4 2025, and $2.7 million in Q3 2025.